| Revision as of 02:13, 4 March 2013 editBill william compton (talk | contribs)Autopatrolled, Extended confirmed users, File movers, Pending changes reviewers, Rollbackers29,264 edits ht:Kanka interwiki link removed← Previous edit | Revision as of 02:14, 4 March 2013 edit undoBill william compton (talk | contribs)Autopatrolled, Extended confirmed users, File movers, Pending changes reviewers, Rollbackers29,264 edits fr:Kanka interwiki link removedTag: Removal of all interwiki links; Wikidata is liveNext edit → | ||
| Line 3: | Line 3: | ||
| {{product-stub}} | {{product-stub}} | ||
| ] | ] | ||
| ] | |||
Revision as of 02:14, 4 March 2013
 | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Kank-A" – news · newspapers · books · scholar · JSTOR (July 2009) (Learn how and when to remove this message) |
Kank-A is a liquid pharmaceutical product marketed by Blistex used primarily to treat canker sores. It is applied directly on the sore and works by numbing the local area (with benzocaine) to prevent discomfort and forming a protective mucous barrier with a compound benzoin tincture that protects the ulcer from further irritation, allowing it to heal more rapidly.
 | This product article is a stub. You can help Misplaced Pages by expanding it. |